ACRS

3.4401.71%
AM

Anand Mehra

Independent Director

Dr. Anand Mehra, M.D. is Founding Partner of Forge Life Science Partners. He served as Independent Non-Executive Chairman of the Board at Merus N.V. since June 2020 until 2026. He also served as Independent Non-Executive Director from August 2015 to June 2020 and as a Member of the Supervisory Board from August 2015 to 2018. He joined firm in August 2015. He serves as Director of Amplyx Pharmaceuticals, Inc. since May 19, 2020 and as an Independent Director of Aclaris Therapeutics, Inc. since September 2014. His prior experience includes experience at Sofinnova Investment, Inc., which he joined in 2007. He served as a General Partner from May 2, 2013 to January 2020, as Partner and as Principal. At the firm, he focused on biopharmaceutical investing, led investments in Vicept Therapeutics, Aerie Pharmaceuticals, Aclaris Therapeutics and Spark Therapeutics and was involved in building the firm’s public market hedge fund practice. He served as an Independent Director of Spark Therapeutics, Inc. from May 2014 to December 17, 2019. He served as an Independent Director at Marinus Pharmaceuticals, Inc. from October 2007 to September 2016. He served as a Director of Aerie Pharmaceuticals, Inc. from August 2010 to November 28, 2015. He served as a Director of Prothena Corporation Public, as a Director of Vicept Therapeutics, Inc. and as a Director of NextWave Pharmaceuticals Incorporated. Prior to joining Sofinnova, he was an Associate of Panorama Capital, where he focused on Life Sciences. He worked in JP Morgan Partners in its private equity and venture capital group and was a Consultant in McKinsey & Company's pharmaceutical practice. He also conducted NIH sponsored research on the outcomes, mechanism and development of therapeutic agents for stroke. He graduated Phi Beta Kappa from the University of Virginia with a B.A. in Foreign Affairs, Government & Political Philosophy and received a M.D. from Columbia University College of Physicians & Surgeons.

Positions